<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: Antiretroviral drugs are associated with <z:e sem="disease" ids="C0235378,C0348754" disease_type="Disease or Syndrome;Injury or Poisoning" abbrv="">hepatotoxicity</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Progress in our knowledge on the prevalence, contributory factors and mechanisms is reviewed </plain></SENT>
<SENT sid="2" pm="."><plain>RECENT FINDINGS: Liver toxicity is highly prevalent and a major cause of hospitalization among HIV-infected individuals </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001397'>Liver steatosis</z:hpo> is probably more frequent in the setting of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus coinfection but is also seen in noncoinfected patients </plain></SENT>
<SENT sid="4" pm="."><plain>Among the individual drugs, severe liver toxicity is more strongly associated with nevirapine, and the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> toxicity of some <z:chebi fb="0" ids="33838">nucleoside</z:chebi> analogues </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> toxicity can also induce or contribute to steatohepatitis, with dietary <z:chebi fb="0" ids="16704">uridine</z:chebi> supplementation as a possible strategy of prevention </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="37924">Atazanavir</z:chebi> inhibits <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase, which in Gilberts' syndrome has been associated with <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>A <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase gene promoter variant predisposes to <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Tipranavir induces <z:hpo ids='HP_0002910'>elevated transaminases</z:hpo> more frequently than boosted comparator <z:chebi fb="0" ids="37670">protease inhibitors</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>CCR5 inhibitors may predispose to hepatotoxic events by causing an imbalance in the cytokine response </plain></SENT>
<SENT sid="10" pm="."><plain>SUMMARY: <z:e sem="disease" ids="C0235378,C0348754" disease_type="Disease or Syndrome;Injury or Poisoning" abbrv="">Hepatotoxicity</z:e> is associated with <z:hpo ids='HP_0000001'>all</z:hpo> classes of antiretroviral agents and continues to contribute to hospitalization </plain></SENT>
</text></document>